Brief: Tetra Bio-Pharma Enters Into Definitive Agreement To Acquire Panag Pharma
Jan 30 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA ENTERS INTO DEFINITIVE AGREEMENT TO
ACQUIRE
PANAG PHARMA INC
* WOULD ACQUIRE 100 PCT OF ISSUED AND OUTSTANDING SHARES OF
PANAG
FOR AN AGGREGATE CONSIDERATION OF $12 MILLION
* AFTER CLOSING OF PROPOSED DEAL, IT IS EXPECTED THAT PANAG
WILL
REMAIN A SEPARATE SUBSIDIARY OWNED 100% BY TETRA
* PURCHASE PRICE WOULD BE PAYABLE BY CO DELIVERING TO
VENDORS,
WOULD BE $3MLN IN CASH, $9MLN IN COMMON SHARES OF CO
Source text for Eikon: ID:nCNWHW58Ra
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding